Vascular Solutions (NSDQ:VASC) wasn’t making friends on Wall Street this week after the company missed expectations for Q1 and lowered its forecast for the rest of the year.
MassDevice Earnings Roundup
Listen to Stryker’s Q1 2014 earnings call
Recall charges continue to suck up Stryker’s profits
Intuitive Surgical sinks following rough Q1 report
Intuitive Surgical (NSDQ:ISRG) dropped more than 11% today as Wall Street reacted to the surgical systems maker’s disappointing 1st-quarter earnings.
Sales, earnings plunge for Intuitive Surgical during dreary Q1
Intuitive Surgical (NSDQ:ISRG) said sales dropped nearly 24% during the first 3 months of 2014, missing analysts’ estimates and sending shares down 4% in after-hours trading.
Baxter blows away Wall Street as renal sales surge in Q1
GE Healthcare’s Q1 sales, profits slide
GE Healthcare (NYSE:GE) saw its sales and profits decline by single digits during the 1st quarter due to "market volatility.”
GE Healthcare posted profits of $570 million on sales of $4.20 billion for the 3 months ended March 31, for a bottom-line decline of 4.2% and a top-line slide of 2.1% compared with the same period last year.
Urologix completes layoffs, announces preliminary results
Abbott’s earnings take a beating in Q1
St. Jude Medical beats The Street, loses points anyway
Minnesota medtech titan St. Jude Medical (NYSE:STJ) lost a few points on Wall Street today after posting 1st quarter earnings a penny above analysts’ consensus estimate.
Johnson & Johnson’s Q1 sales, earnings beat forecasts
Johnson & Johnson (NYSE:JNJ) topped expectations with its 1st-quarter results and raised its outlook for the rest of the year, sending share prices up this morning.